C. Duggan Evans

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

Bradford C. Dickerson, Bruce L. Miller, Murray Grossman, 2020, Nature Medicine.

Donanemab in Early Alzheimer's Disease.

M. Mintun, L. Apostolova, S. Salloway, 2021, The New England journal of medicine.

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

K. Blennow, B. Dickerson, D. Airey, 2020, Nature Medicine.

Donanemab (LY3002813) Phase 1b Study in Alzheimer’s Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging

A. Fleisher, J. Dage, S. Shcherbinin, 2021, The Journal of Prevention of Alzheimer's Disease.